Berkley Capital, Llc Sells 100,000 Shares of Healthequity Inc (HQY) Stock

Healthequity Inc (NASDAQ:HQY) insider Berkley Capital, Llc sold 100,000 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $51.25, for a total transaction of $5,125,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Berkley Capital, Llc also recently made the following trade(s):

  • On Monday, February 12th, Berkley Capital, Llc sold 350,000 shares of Healthequity stock. The shares were sold at an average price of $52.12, for a total transaction of $18,242,000.00.
  • On Wednesday, November 29th, Berkley Capital, Llc sold 700 shares of Healthequity stock. The shares were sold at an average price of $52.05, for a total transaction of $36,435.00.
  • On Monday, November 27th, Berkley Capital, Llc sold 12,300 shares of Healthequity stock. The shares were sold at an average price of $52.14, for a total transaction of $641,322.00.
  • On Wednesday, November 22nd, Berkley Capital, Llc sold 11,200 shares of Healthequity stock. The shares were sold at an average price of $51.54, for a total transaction of $577,248.00.
  • On Friday, November 24th, Berkley Capital, Llc sold 77,221 shares of Healthequity stock. The shares were sold at an average price of $51.31, for a total transaction of $3,962,209.51.
  • On Thursday, November 16th, Berkley Capital, Llc sold 23,479 shares of Healthequity stock. The shares were sold at an average price of $51.08, for a total transaction of $1,199,307.32.

Shares of Healthequity Inc (NASDAQ:HQY) traded up $1.36 during trading on Monday, reaching $52.65. 979,509 shares of the company’s stock were exchanged, compared to its average volume of 475,368. The stock has a market cap of $3,190.00, a P/E ratio of 71.15, a P/E/G ratio of 1.96 and a beta of 1.70. Healthequity Inc has a 52 week low of $37.62 and a 52 week high of $55.31.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. Healthequity’s quarterly revenue was up 31.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.10 EPS. sell-side analysts predict that Healthequity Inc will post 0.73 EPS for the current fiscal year.

HQY has been the subject of several research reports. BidaskClub downgraded shares of Healthequity from a “hold” rating to a “sell” rating in a research report on Wednesday, October 18th. Zacks Investment Research downgraded shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Friday, November 3rd. Chardan Capital upped their price target on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 price objective on shares of Healthequity in a research report on Tuesday, December 5th. Finally, Citigroup initiated coverage on shares of Healthequity in a research report on Thursday, January 4th. They set a “buy” rating for the company. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Healthequity presently has an average rating of “Buy” and an average target price of $56.67.

Institutional investors have recently made changes to their positions in the business. Zions Bancorporation purchased a new position in shares of Healthequity in the 3rd quarter valued at about $119,000. Catalyst Capital Advisors LLC purchased a new position in shares of Healthequity in the 4th quarter valued at about $149,000. CIBC Asset Management Inc purchased a new position in shares of Healthequity in the 3rd quarter valued at about $208,000. 1st Global Advisors Inc. purchased a new position in shares of Healthequity in the 2nd quarter valued at about $213,000. Finally, Shelton Capital Management purchased a new position in shares of Healthequity in the 2nd quarter valued at about $217,000. Institutional investors own 98.63% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/12/berkley-capital-llc-sells-100000-shares-of-healthequity-inc-hqy-stock.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply